Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2

Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2

Multiple outbreaks of epidemic and pandemic viral diseases have occurred in the last 20 years, including those caused by Ebola virus, Zika virus, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence or re-emergence of such diseases has revealed the deficiency in our pipeli...

Full description

Bibliographic Details
Main Authors: Miray Tonk, Daniel Růžek, Andreas Vilcinskas
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Viruses
Subjects:
SARS-CoV-2
COVID-19
coronavirus
antimicrobial peptides
antiviral peptides
defensins
Online Access:https://www.mdpi.com/1999-4915/13/5/912

Similar Items

Similar Items